Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.eururo.2020.03.026 http://scihub22266oqcxt.onion/10.1016/j.eururo.2020.03.026 32312544!7164868!32312544     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Urol 2020 ; 77 (6): 667-668 Nephropedia Template TP {{tp|p=32312544|t=2020. Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic |pdf=|usr=}}{{32312544}} gab.com Text Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic JO: Eur Urol http://www.kidney.de/pget.php?&tw=1&pmid=32312544 #FOAvip The risk/benefit ratio of a number of palliative and (neo)adjuvant treatments should be reconsidered during the COVID-19 pandemic. We provide treatment advice as a pragmatic perspective on the risk/benefit ratio in specific clinical scenarios. Twit Text FOAVip Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic ????Eur Urol http://www.kidney.de/pget.php?&tw=1&pmid=32312544 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32312544 #FOAvip English Wikipedia <ref>{{Cite pmid|32312544}}</ref> Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic #MMPMID32312544 Gillessen S; Powles T Eur Urol 2020[Jun]; 77 (6): 667-668 PMID32312544show ga The risk/benefit ratio of a number of palliative and (neo)adjuvant treatments should be reconsidered during the COVID-19 pandemic. We provide treatment advice as a pragmatic perspective on the risk/benefit ratio in specific clinical scenarios. |*Disease Transmission, Infectious/prevention & control[MESH] |Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use[MESH] |Betacoronavirus/*pathogenicity[MESH] |COVID-19[MESH] |Chemotherapy, Adjuvant[MESH] |Clinical Decision-Making[MESH] |Coronavirus Infections/mortality/prevention & control/transmission/*virology[MESH] |Humans[MESH] |Neoadjuvant Therapy[MESH] |Palliative Care[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/mortality/prevention & control/transmission/*virology[MESH] |Practice Guidelines as Topic[MESH] |Risk Assessment[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH]Advice Regarding Systemic Therapy in Patients with Urological Cancers (epmc).pdf DeepDyve Pubget Overpricing